Page last updated: 2024-09-04

naphthalenesulfonamide and sulfanilamide

naphthalenesulfonamide has been researched along with sulfanilamide in 2 studies

Compound Research Comparison

Studies
(naphthalenesulfonamide)
Trials
(naphthalenesulfonamide)
Recent Studies (post-2010)
(naphthalenesulfonamide)
Studies
(sulfanilamide)
Trials
(sulfanilamide)
Recent Studies (post-2010) (sulfanilamide)
16046,4804433

Protein Interaction Comparison

ProteinTaxonomynaphthalenesulfonamide (IC50)sulfanilamide (IC50)
Carbonic anhydrase 1Homo sapiens (human)0.921
Carbonic anhydrase 2Homo sapiens (human)2.043
Carbonic anhydrase 6Homo sapiens (human)0.921
Carbonic anhydrase 9Homo sapiens (human)0.294

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franchi, M; Gallori, E; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D1
Jaiswal, M; Khadikar, PV; Scozzafava, A; Supuran, CT1

Other Studies

2 other study(ies) available for naphthalenesulfonamide and sulfanilamide

ArticleYear
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
    Bioorganic & medicinal chemistry letters, 2003, Mar-24, Volume: 13, Issue:6

    Topics: Animals; Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cattle; Heterocyclic Compounds; Humans; Hydrocarbons, Aromatic; Isoenzymes; Kinetics; Neoplasm Proteins; Neoplasms; Structure-Activity Relationship; Sulfonamides

2003
Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.
    Bioorganic & medicinal chemistry letters, 2004, Jun-21, Volume: 14, Issue:12

    Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Isoenzymes; Quantitative Structure-Activity Relationship; Sulfonamides

2004